Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann to Ring Nasdaq Stock Market Closing Bell on May 6th
 |
| Pippa Mann in Times Square (see video below) |
Verizon IndyCar Series driver Pippa Mann, entered to drive the No. 63 Dale Coyne Racing Honda in this year's Indianapolis 500, helped new sponsor Genetic Technologies Limited (a molecular diagnostics company specializing in women's health) ring the closing bell at the NASDAQ MarketSite in New York City's Times Square.
"The event has additional meaning to us," said Eutillio Buccilli, CEO of Genetic Technologies, "as it ceremoniously marks, in earnest, the beginning of our partnership with Pippa Mann, a next-generation athlete who has demonstrated true conviction and commitment to promoting women's health and in particular, breast cancer awareness."
Mann will once again be promoting her 2016 Pink #GetInvolved campaign with her Indy 500 car, raising funds for Susan G. Komen, the world's largest nonprofit source of funding for the fight against breast cancer. See video below.
 |
| Pippa Mann |
05/04/16 Genetic Technologies Limited, a molecular diagnostics company specializing in women's health, and provider of BREVAGenplus, a first-in-class, clinically validated risk assessment test for sporadic breast cancer, announced today that it will visit the Nasdaq MarketSite in New York City's Times Square and ring the Closing Bell on Friday, May 6th, 2016. Eutillio Buccilli, Chief Executive Officer of Genetic Technologies, will be joined by international race car driver and BREVAGenplus spokesperson, Pippa Mann, to perform the honorary ringing of the bell. The Closing Bell will ring at 4.00pm ET and will be televised on major U.S. finance and business networks or can be viewed online here or here.
"We are extremely pleased to be invited to the Nasdaq MarketSite for the ceremonial bell ringing at this exciting time for the Company as we ramp-up commercial activities for BREVAGenplus," commented Eutillio Buccilli, Chief Executive Officer of Genetic Technologies. "The event has additional meaning to us as it ceremoniously marks, in earnest, the beginning of our partnership with Pippa Mann, a next generation athlete who has demonstrated true conviction and commitment to promoting women's health and in particular, breast cancer awareness."
This past February, Genetic Technologies announced a partnership with Pippa Mann as part of a marketing program to raise the profile of BREVAGenplus. Mann is one of only nine female athletes to ever compete in the Indianapolis 500 and the only female driver to start in the race over the past three consecutive years. The BREVAGenplus logo will feature on Mann's racing and promotional apparel as well as the Dale Coyne Racing car supporting Susan G. Komen. In addition to Mann's participation in key BREVAGenplus oriented events, her messaging and images will also appear in the Company's promotional print, video and social media platforms. The 100th running of the Indianapolis 500 on May 29, 2016 will serve as the first event under the partnership program.